SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (379)1/8/2003 7:06:56 PM
From: mopgcw  Read Replies (1) | Respond to of 598
 
Thanks! must be patient, must be patient (eom)



To: keokalani'nui who wrote (379)1/8/2003 7:17:21 PM
From: scaram(o)uche  Respond to of 598
 
Thanks! Goeddel or Perlman or ??????

1-2 INDs? If they hit *one*, that will be the upper limit of the 2002 objectives, combining 2002 and 2003. I feel that the objective should have been AT LEAST TWO.

It's "catch up time", Dr. Goedell. You need to be a phenom, given past screwups.



To: keokalani'nui who wrote (379)1/8/2003 7:43:55 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 598
 
>> CXCR3 “Essentially no SEs of any time in P1.” <<

Cool. Good.

>> Multi dose Proof of concept P2 in RA and psoriasis starts in 4Q03. <<

Uh..... 4Q??

Archives are up for most presentations, but not yet for TLRK.